The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 23, 2022

Filed:

Nov. 23, 2021
Applicant:

Inventure, Llc, Southbury, CT (US);

Inventors:

Richard Deslauriers, Woodbury, CT (US);

Michael Milbocker, Holliston, MA (US);

Assignee:

Inventure, LLC, Southbury, CT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/10 (2006.01); A61K 49/18 (2006.01);
U.S. Cl.
CPC ...
A61K 49/108 (2013.01); A61K 49/1806 (2013.01);
Abstract

Gadolinium based contrast agents (GCA) incorporating linear ligand chelation are fundamentally different from GCAs incorporating macrocyclic ligands. The macrocyclic\GCAs are synthesized by pathways characterized by the formation of a sequence of metastable complexes before obtaining the final stable complex. The synthesis of linear GCAs do not form metastable complexes. Commercial macrocyclic GCAs contain unstable metastable complexes. These metastable species are not regulated and quickly release free Gd3+ ions upon administration into the body. Gadolinium based contrast agents with near zero metastable species content and methods of synthesizing the same are disclosed. Gadolinium based contrast agents with long dissociation time in the body, and low free Gd3+ ion formation are obtained using a synthesis method which departs in novel ways from the traditional free Gd3+-based synthesis methods.


Find Patent Forward Citations

Loading…